This track will explore the latest innovations in cancer diagnostic techniques, including imaging and biomarker discovery. Emphasis will be placed on enhancing early detection and improving patient outcomes.

This session will delve into the fundamental biological mechanisms underlying cancer development and progression. Discussions will include genetic, epigenetic, and microenvironmental factors influencing tumor behavior.

This track will focus on the latest therapeutic approaches in oncology, including chemotherapy, targeted therapies, and immunotherapy. Participants will discuss the efficacy and safety profiles of emerging treatment options.

This session will address the disparities in cancer incidence, treatment, and outcomes among different populations. Strategies for improving access to care and reducing inequities will be highlighted.

This track will cover best practices in the clinical management of breast and cervical cancers, including screening, treatment protocols, and survivorship care. Emphasis will be placed on multidisciplinary approaches to enhance patient care.

This session will focus on the role of the immune system in cancer and the development of immunotherapeutic strategies. Topics will include checkpoint inhibitors, CAR T-cell therapy, and vaccine development.

This track will examine the role of viral infections in cancer pathogenesis and the implications for prevention and treatment. Discussions will include HPV, HBV, and other oncogenic viruses.

This session will explore the impact of environmental factors on cancer risk and the development of effective prevention strategies. Topics will include exposure assessment and public health interventions.

This track will focus on the development and application of chemical agents in cancer treatment. Participants will discuss novel compounds, combination therapies, and resistance mechanisms.

This session will highlight advancements in imaging technologies for cancer diagnosis and monitoring. Emphasis will be placed on the integration of imaging with therapeutic decision-making.

This track will address the importance of multidisciplinary collaboration in cancer care. Discussions will focus on team-based approaches to improve treatment outcomes and patient quality of life.